Next generation organ-on-a-chip technology adopted by King’s College London
June 29, 2021Manufacturing and Production organ-on-a-chip, research collaboration, technology, university
CN Bio, an organ-on-a-chip company that designs and manufactures single and multi-organ microphysiological systems (MPS), has announced that their novel …
CHMP issue positive opinion for Incyte and MorphoSys’ tafasitamab
June 29, 2021Manufacturing and Production CHMP, EMA, EU, FDA, US
Incyte and MorphoSys have announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive …
Quantoom & eTheRNA to collaborate on revolutionary RNA production system
June 29, 2021Manufacturing and Production RNA, collaboration
Quantoom and eTheRNA immunotherapies have announced a strategic collaboration to develop a revolutionary RNA production system (RPS) for both research …
NICE recommends that all women should do pelvic floor exercises
June 29, 2021Manufacturing and Production NHS, NICE, pelvic floor, women's health
NICE has recommended in draft guidance that girls as young as 12 should be encouraged to do pelvic floor muscle …
Avacta’s lateral flow test can detect Delta variant
June 29, 2021Manufacturing and Production Avacta, COVID-19, Delta variant, antigen lateral flow test
A study has shown that Avacta’s AffiDX antigen lateral flow test can detect the Delta variant of COVID-19. The test …
Astellas receives positive CHMP opinion for symptomatic anaemia drug
June 28, 2021Sales and Marketing Astellas, CKD, anaemia
Astellas and FibroGen have announced that the Committee for Medicinal Products for Human Use (CHMP) of the EMA has adopted …
Samsung Bioepis & Biogen receive positive CHMP opinion for ranibizumab biosimilar
June 28, 2021Sales and Marketing EC, EMA, EU, biosimilars
Samsung Bioepis and Biogen have announced that the EMA’s Committee for Medicinal Products for Human Use (CHMP) has adopted a …
Eli Lilly’s Type 2 diabetes drug outperforms semaglutide in trials
June 28, 2021Sales and Marketing Eli Lilly, semaglutide, type 2 diabetes
Eli Lilly has announced that the SURPASS-2 clinical trial has shown tirzepatide achieved superior HbA1C and body weight reductions compared …
Polyphor’s future in question after co-primary endpoint in breast cancer study missed
June 28, 2021Sales and Marketing Primary Endpoint, breast cancer
Swiss biopharmaceutical company, Polyphor, has announced that its global Phase III study, FORTRESS, evaluating balixafortide (POL6326) in combination with eribulin …
Medical cannabis formulation kills breast cancer cells in trial
June 28, 2021Sales and Marketing breast cancer, medical cannabis, oncology
UK-based pharma company, Apollon Formularies, have announced that their medical cannabis formulations were successful in killing triple-negative breast cancer (TNBC) …
Tapeworm drug to be trialled nationally as COVID treatment
June 25, 2021Medical Communications COVID-19, NHS, dialysis, kindey, tapeworm
Kidney patients in Bristol are being offered a clinical trial to see whether a drug used for tapeworm patients can …
Eli Lilly to seek FDA approval for experimental Alzheimer’s drug
June 25, 2021Medical Communications Alzheimer's, Eli Lilly, FDA
Eli Lilly plans to seek accelerated FDA approval for its experimental Alzheimer’s drug donanemab, announcing plans on Thursday to file …
Exscientia to collaborate with EQRx on drug development
June 25, 2021Medical Communications AI, Exscientia, clinical drug development
Exscientia and EQRx have announced a strategic research and development collaboration agreement aiming to substantially accelerate the delivery of novel …
New test proven to detect over 50 types of cancer
June 25, 2021Medical Communications Cancer. test, US, oncology
Final results from a study into a new blood test that can detect more than 50 types of cancer have …
Sanofi’s NSCLC drug gains EC approval
June 25, 2021Medical Communications EC, EU, NSCLC, Sanofi
The European Commission (EC) has approved Sanofi and Regeneron’s PD-1 inhibitor, Libtayo (cemiplimab), for the first-line treatment of adults with …
Novartis announce digital collaboration with HPE
June 24, 2021AI, HPE, Novartis
Swiss pharma company, Novartis, has announced a collaboration with Hewlett Packard Enterprise (HPE), to accelerate its use of data and …
Kite’s leukaemia cell therapy application validated by EMA
June 24, 2021EMA, Kite, leukemia
Kite has announced that their Type II variation application for a new indication to the approved license for autologous anti-CD19-transduced …
AstraZeneca’s Lynparza for prostate cancer approved in China
June 24, 2021AstraZeneca and MSD’s Lynparza has received conditional approval in China for the treatment of patients with BRCA-mutated metastatic castration-resistant prostate …
Survey reveals over 2 million people impacted by long COVID in UK
June 24, 2021COVID-19, UK, government, long covid, study
A recent survey from Imperial College London has revealed that over 2 million people in the UK may have suffered …
MHRA and EC approve Leo Pharma’s Adtralza for atopic dermatitis
June 24, 2021The MHRA and EC have approved Leo Pharma’s Adtralza (tralokinumab) for adults with moderate-to-severe atopic dermatitis who are candidates for …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
